Authors:
CHARTIER S
FAUCHER L
TOUSIGNANT J
ROCHETTE L
Citation: S. Chartier et al., ACQUIRED CUTIS LAXA ASSOCIATED WITH CUTANEOUS ANGIOCENTRIC T-CELL LYMPHOMA, International journal of dermatology, 36(10), 1997, pp. 772-776
Authors:
SOIFFER RJ
MURRAY C
SHAPIRO C
COLLINS H
CHARTIER S
LAZO S
RITZ J
Citation: Rj. Soiffer et al., EXPANSION AND MANIPULATION OF NATURAL-KILLER-CELLS IN PATIENTS WITH METASTATIC CANCER BY LOW-DOSE CONTINUOUS-INFUSION AND INTERMITTENT BOLUS ADMINISTRATION OF INTERLEUKIN-2, Clinical cancer research, 2(3), 1996, pp. 493-499
Authors:
PIGNATA C
SANGHERA JS
SOIFFER RJ
CHARTIER S
EDER M
PELECH SL
RITZ J
Citation: C. Pignata et al., DEFECTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(6), 1996, pp. 2334-2341
Citation: Jl. Senecal et al., HYPERGAMMAGLOBULINEMIC PURPURA IN SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES - PREDICTIVE VALUE OF ANTI-RO(SSA) AND ANTI-LA(SSB) ANTIBODIES ANDTREATMENT WITH INDOMETHACIN AND HYDROXYCHLOROQUINE, Journal of rheumatology, 22(5), 1995, pp. 868-875
Authors:
VISSAC AM
GRIMAUX M
CHARTIER S
CHAN FA
CHAMBRETTE B
AMIRAL J
Citation: Am. Vissac et al., A NEW SENSITIVE MEMBRANE-BASED ELISA TECHNIQUE FOR INSTANTANEOUS D.DIMER EVALUATION IN EMERGENCY, Thrombosis research, 78(4), 1995, pp. 341-352
Authors:
ALYEA E
SOIFFER R
MURRAY C
BARTETTPANDITE L
COLLINS H
PICKETT C
WANG Y
CHARTIER S
ANDERSON K
RITZ J
Citation: E. Alyea et al., ADOPTIVE IMMUNOTHERAPY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) WITH DONOR LYMPHOCYTES DEPLETED OF CD8-CELLS( T), Blood, 86(10), 1995, pp. 1158-1158
Authors:
LEFEBVRE C
TOUSIGNANT J
CHARTIER S
DEMERS D
Citation: C. Lefebvre et al., COLIC ADENOCARCINOMA AND PROGRESSIVE SYST EMIC SCLERODERMA, Annales de dermatologie et de venereologie, 120(4), 1993, pp. 293-295
Authors:
SOIFFER RJ
GONIN R
MURRAY C
ROBERTSON MJ
COCHRAN K
CHARTIER S
CAMERON C
DALEY J
LEVINE H
NADLER LM
RITZ J
Citation: Rj. Soiffer et al., PREDICTION OF GRAFT-VERSUS-HOST DISEASE BY PHENOTYPIC ANALYSIS OF EARLY IMMUNE RECONSTITUTION AFTER CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(7), 1993, pp. 2216-2223